HPV Testing and Pap Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented Test Type (HPV Test, Pap Test, Co-testing), By Application (Cervical Cancer Screening Test, Head and Neck Cancer Screening Test, Other Applications), By End User (Hospitals/Clinics, Diagnostic Centers, Point-of-Care/Self-sampling) By Region and Competition

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

HPV Testing and Pap Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented Test Type (HPV Test, Pap Test, Co-testing), By Application (Cervical Cancer Screening Test, Head and Neck Cancer Screening Test, Other Applications), By End User (Hospitals/Clinics, Diagnostic Centers, Point-of-Care/Self-sampling) By Region and Competition

Forecast Period2024-2028
Market Size (2022)USD 4.03 billion
CAGR (2023-2028)10.89%
Fastest Growing SegmentHospitals
Largest MarketNorth America
MIR Consumer Healthcare

Market Overview

Key Market Drivers

Rising Cervical Cancer Incidence and Mortality Rates

Advancements in Diagnostic Technologies

MIR Segment1

Growing Awareness and Education

Key Market Challenges

Limited Access to Healthcare Services

Vaccine Hesitancy

MIR Regional

Socioeconomic Disparities

Key Market Trends

Rapid Adoption of HPV DNA Testing

Liquid-Based Cytology for Pap Smears

Segmental Insights

Test Type Insights

Application Insights

Regional Insights

Recent Developments

  • In June 2022, Roche announced the introduction of an HPV self-samplingsolution in nations that recognise the CE mark. A patient can now quietlyobtain a sample for HPV screening thanks to this new solution. On a Rochemolecular device, the clinically verified vaginal sample is examined with theRoche Cobas HPV test.
  • In May 2021, According to the IVD directive 98/79/EC, Becton, Dickinson,and Company declared that the first self-collection claim for HPV screening inthe industry has received CE marking. With the help of a BD diluent tube andthe BD Onclarity HPV Assay on either the BD Viper LT or the BD COR System, thenew claim enables labs and facilities to process self-collected samples.

Key Market Players

  • Arbor Vita Corporation
  • DanaherCorporation (Cepheid)
  • SeegeneInc.
  • Becton,Dickinson and Company
  • TruScreen
  • AbbottLaboratories
  • HologicInc.
  • QiagenNV
  • F.Hoffmann-La Roche AG
  • OncoHealthCorporation

 By Test Type

By End User

By Application

By Region
  • HPV Test
  • Pap Test
  • Co-testing
  • Hospitals/Clinics Diagnostic Centers
  • Point-of-Care/Self-sampling
  • Cervical Cancer Screening Test
  • Head and Neck Cancer Screening Test
  • Other Applications
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email